Publication | Open Access

A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503

Second Line TreatmentOncologyPhase Ii TrialMetronomic TherapyBronchial NeoplasmPharmacotherapyCancer TreatmentMedicineRadiation OncologyLung CancerCancer Research